Does riboflavin (vitamin B2) deficiency cause clinically significant skin changes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, vitamin B2 (riboflavin) deficiency causes clinically significant skin changes.

Riboflavin deficiency manifests with characteristic dermatologic findings, most notably seborrheic dermatitis affecting the face, trunk, and scrotum, along with oral-buccal lesions including cheilosis (cracked lips), angular stomatitis (cracks at mouth corners), and glossitis (inflamed tongue) 1.

Clinical Manifestations of Riboflavin Deficiency

Skin Changes

The dermatologic manifestations are clinically significant and include:

  • Seborrheic dermatitis: Affects the face, trunk, and scrotum with a characteristic greasy, scaly appearance 1
  • Distribution varies by age and gender: The pattern of skin involvement differs between acute and chronic deficiency 2
  • Acute deficiency: Lesions resemble those seen in protein-energy malnutrition (kwashiorkor type) 2
  • Chronic deficiency: Cutaneous lesions can mimic monilial intertrigo 2

Mucosal Changes

Equally prominent are the oral manifestations:

  • Cheilosis (lip fissuring)
  • Angular stomatitis (painful cracks at mouth corners)
  • Glossitis (smooth, magenta-colored tongue) 1

Other Clinical Features

Beyond skin, riboflavin deficiency causes:

  • Ocular symptoms: Itching, burning, dryness, corneal inflammation, and photophobia 1
  • Hematologic effects: Normochromic, normocytic anemia and bone marrow aplasia 1
  • Iron metabolism impairment: Interferes with iron absorption and mobilization from ferritin stores 1, 3

Diagnostic Confirmation

The diagnosis is confirmed by rapid resolution of lesions after therapeutic doses of riboflavin 2. Treatment with riboflavin 5-10 mg/day orally typically leads to recovery, though severe cases may require IV administration of 160 mg for 4 days, with clinical cure achieved within 10 days 1.

Important Clinical Caveats

Co-existing Deficiencies

Riboflavin deficiency rarely occurs in isolation—it is frequently associated with deficiencies of pyridoxine (B6), folate, and niacin, which produce overlapping symptoms 1. This makes clinical diagnosis challenging, as the skin manifestations may represent multiple vitamin deficiencies simultaneously.

At-Risk Populations

Screen for riboflavin deficiency in patients with:

  • Malabsorption syndromes (short bowel syndrome, celiac disease)
  • Chronic kidney disease (pre-dialysis, hemodialysis, peritoneal dialysis)
  • Alcoholism
  • Thyroid dysfunction or diabetes
  • Recent surgery, trauma, burns, or fractures
  • Use of psychotropic drugs, tricyclic antidepressants, or barbiturates
  • Pregnancy, lactation, or elderly status
  • Anorexia nervosa with dairy avoidance 1

Subclinical Deficiency

One critical pitfall: subclinical riboflavin deficiency may be widespread even in high-income countries but goes undetected because riboflavin biomarkers are rarely measured 4. A case report documented low plasma riboflavin levels without clinical symptoms in a patient receiving intermittent rather than daily supplementation 1, suggesting biochemical deficiency can precede overt clinical signs.

Severe Presentations

Recent case reports demonstrate that severe riboflavin deficiency during prolonged parenteral nutrition can present with life-threatening manifestations including refractory lactic acidosis, multiorgan failure, and skin rash 5, emphasizing the critical importance of adequate supplementation in high-risk clinical scenarios.

Assessment Strategy

When clinical suspicion exists based on the characteristic mucocutaneous findings:

  • Measure erythrocyte glutathione reductase activity (functional assay, more reliable than plasma levels, especially during inflammation) 1
  • Alternative: Red blood cell FAD levels, particularly useful in inflammatory states 1
  • Do not wait for laboratory confirmation if clinical signs are present—initiate empiric treatment given the safety profile and rapid response 1

The 2022 ESPEN guidelines provide the most authoritative framework for recognizing and managing these clinically significant dermatologic manifestations of riboflavin deficiency 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.